Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28154184 | 1.00 | KDM4E (0.32) | KDM4EMAPK1TDP1LMNAALOX15 | |
| SCHEMBL15846389 | 0.83 | MAPK1 (0.33) | MAPK1 | |
| SCHEMBL599525 | 0.82 | KDM4E (0.37) | KDM4E | |
| SCHEMBL247843 | 0.82 | KDM4E (0.37) | KDM4E | |
| SCHEMBL3225658 | 0.82 | MAPK1 (0.31) | MAPK1TDP1LMNAALOX15BLM | |
| SCHEMBL3225664 | 0.82 | MAPK1 (0.31) | MAPK1TDP1LMNAALOX15BLM | |
| SCHEMBL11503593 | 0.80 | TRPA1 (0.31) | MAPK1 | |
| Ammonia Solution, Strong SCHEMBL5698791 | 0.80 | MAPK1 (0.30) | MAPK1 | |
| SCHEMBL337182 | 0.80 | MAPK1 (0.30) | MAPK1 | |
| SCHEMBL4531663 | 0.80 | MAPK1 (0.30) | MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040137028-A1 | Transfer-free cosmetic composition comprising a dispersion of polymer particles and a specific rheological agent | L'OREAL | 2004-07-15 | — | — | US | disclosed |
| US-6326013-B1 | TRANSFER-RESISTANT MAKE-UP | L'OREAL (FR) | 2001-12-04 | — | — | US | disclosed |
| US-20010006665-A1 | Composition comprising at least one wax and at least one oil | L'OREAL S.A. (FR) | 2001-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010006665-A1 | Composition comprising at least one wax and at least one oil | CUTA, COL14A1, LIPA | KDM4E 4531/4885MAPK1 2772/4885TDP1 866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.